Serum Extracellular Vesicles Retard H9C2 Cell Senescence by Suppressing miR-34a Expression
- 177 Downloads
Extracellular vesicles (EVs) are small-sized membrane-surrounded structures released from cells into the blood, which play important roles in regulating various biological processes. However, the role of EVs in Doxorubicin (DOX)-induced cardiomyocytes senescence remains elusive. In this study, we found that human serum EVs inhibited DOX-induced senescence in H9C2 cells, which was abolished by miR-34a mimic. Our study also proved that miR-34a mediated DOX-induced H9C2 cell senescence by targeting phosphatase 1 nuclear targeting subunit (PNUTS). In addition to the downregulation of miR-34a, EVs could upregulate the expression of PNUTS. Moreover, the inhibitory effect of serum EVs on DOX-induced H9C2 cell senescence was also impeded by PNUTS siRNA. In conclusion, our study suggests that serum EVs retard H9C2 cell senescence through the miR-34a/PNUTS pathway, providing a potential therapy for cardiac aging.
KeywordsSerum extracellular vesicles Cell senescence miR-34a Phosphatase 1 nuclear targeting subunit
This work was supported by the grants from National Natural Science Foundation of China (81470515, 81670362, and 81600228) and Shanghai Medical Guide Project from Shanghai Science and Technology Committee (134119a3000).
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Research Involving Human Participants and/or Animals
All human investigations conformed to the principles outlined in the Declaration of Helsinki and were approved by the institutional review committees of Shanghai Tongji Hospital.
- 1.Agarwal, U., George, A., Bhutani, S., Ghosh-Choudhary, S., Maxwell, J. T., Brown, M. E., et al. (2017). Experimental, systems, and computational approaches to understanding the MicroRNA-mediated reparative potential of cardiac progenitor cell-derived exosomes from pediatric patients. Circulation Research, 120(4), 701–712.CrossRefGoogle Scholar
- 4.Kishore, R., & Khan, M. (2017). Cardiac cell-derived exosomes: changing face of regenerative biology. European Heart Journal, 38(3), 212–215.Google Scholar
- 8.Zhang, Z., Yang, J., Yan, W., Li, Y., Shen, Z., & Asahara, T. (2016). Pretreatment of cardiac stem cells with exosomes derived from mesenchymal stem cells enhances myocardial repair. Journal of the American Heart Association, 5(1). https://doi.org/10.1161/JAHA.115.002856.
- 13.Dimitrakopoulos, G. N., Dimitrakopoulou, K., Maraziotis, I. A., Sgarbas, K., & Bezerianos, A. (2014). Supervised method for construction of microRNA-mRNA networks: application in cardiac tissue aging dataset. Conference Proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2014, 318–321.Google Scholar
- 28.Emanueli, C., Shearn, A. I., Laftah, A., Fiorentino, F., Reeves, B. C., Beltrami, C., et al. (2016). Coronary artery-bypass-graft surgery increases the plasma concentration of exosomes carrying a cargo of cardiac MicroRNAs: an example of exosome trafficking out of the human heart with potential for cardiac biomarker discovery. PLoS One, 11(4), e0154274.CrossRefGoogle Scholar